Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
NCC A | NCCA | 22. nov 2024 | 161.50 | +1.25 |
NCC B | NCCB | 22. nov 2024 | 160.40 | +1.65 |
Nederman Holding | NMAN | 22. nov 2024 | 219.50 | +0.23 |
NEL | NELO | 22. nov 2024 | 3.00 | +1.97 |
Nelly Group | NELLY | 22. nov 2024 | 28.55 | +3.63 |
Neobo Fastigheter | NEOBO | 22. nov 2024 | 20.49 | +1.19 |
Neola Medical | NEOLA | 22. nov 2024 | 2.90 | +6.62 |
Neovici Holding B | NEOB | 22. nov 2024 | 9.50 | +3.83 |
Nepa | NEPA | 22. nov 2024 | 19.60 | +2.89 |
Net Insight B | NETIB | 22. nov 2024 | 6.76 | -0.15 |
Netel | NETEL | 22. nov 2024 | 13.34 | -1.19 |
NetJobs Group | NJOB | 22. nov 2024 | 0.33 | 0.00 |
New Nordic Healthbrands | NNH | 22. nov 2024 | 15.00 | 0.00 |
New Wave B | NEWAB | 22. nov 2024 | 96.60 | +1.10 |
Newbury Pharmaceuticals | NEWBRY | 22. nov 2024 | 3.32 | -5.68 |
Newlist | NEWL | 22. nov 2024 | 0.09 | -3.16 |
Nexam Chemical Holding | NEXAM | 22. nov 2024 | 4.19 | +2.70 |
Nexar Group | NXAR | 22. nov 2024 | 0.22 | -18.25 |
NextCell Pharma AB | NXTCL | 22. nov 2024 | 1.73 | -1.70 |
NFO Drives | NFO | 22. nov 2024 | 34.40 | +0.58 |
Ngenic | NGENIC | 22. nov 2024 | 1.70 | +0.30 |
NGS Group | NGS | 22. nov 2024 | 3.12 | 0.00 |
Nibe Industrier B | NIBEB | 22. nov 2024 | 45.75 | +1.87 |
Nicoccino Holding | NICO | 22. nov 2024 | 1.69 | +5.63 |
Nidhogg Resources Holding AB | NIDHOG | 22. nov 2024 | 0.02 | -3.67 |
Nilsson Special Vehicles | NILS | 22. nov 2024 | 2.98 | -1.97 |
Nilörngruppen B | NILB | 22. nov 2024 | 67.00 | +1.21 |
Nimbus Group | BOAT | 22. nov 2024 | 16.20 | -0.61 |
Nischer Properties | NIS | 22. nov 2024 | 0.30 | -14.57 |
Nitro Games | NITRO | 22. nov 2024 | 2.30 | +0.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.